Tenaya Therapeutics, Inc.
Ticker: TNYA
| Insider | Title |
|---|---|
| Amy L. Burroughs | Director |
| Capital, Llc Casdin | Director |
| Catherine Stehman-breen | Director |
| Chihiro Saito | SVP, Accounting and Fin. Ops. |
| David V Goeddel | Director, 10% or greater ownership |
| Deepak Srivastava | Director |
| Eli Casdin | Director |
| Faraz Ali | Chief Executive Officer, Director |
| Group Iii Gp, Lp Column | 10% or greater ownership |
| Group Iii, Lp Column | 10% or greater ownership |
| Group Iii-a, Lp Column | 10% or greater ownership |
| Group Opportunity Iii Gp, Lp Column | 10% or greater ownership |
| Group Opportunity Iii, Lp Column | 10% or greater ownership |
| Jeenjoo Kang | Director |
| Jeffrey T. Walsh | Director |
| Jin-long Chen | Director |
| June Lee | Director |
| Karah Herdman Parschauer | Director |
| Leone D Patterson | Chief Fin. and Bus. Officer |
| Opportunity Iii Gp, Llc Tcg | 10% or greater ownership |
| Partners Master Fund, L.p. Casdin | 10% or greater ownership |
| Private Growth Equity Fund Gp, Llc Casdin | 10% or greater ownership |
| Private Growth Equity Fund, L.p. Casdin | 10% or greater ownership |
| R Sanders Williams | Director |
| Timothy Hoey | Chief Scientific Officer |
| Whittemore Tingley | Chief Medical Officer |